Literature DB >> 28771026

Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.

Nagendran Tharmalingam1, Elamparithi Jayamani1,2, Rajmohan Rajamuthiah1, Dawilmer Castillo1, Beth Burgwyn Fuchs1, Michael J Kelso3, Eleftherios Mylonakis1.   

Abstract

AIM: Compound 1-(4-chlorophenyl)-4,4,4-trifluoro-3-hydroxy-2-buten-1-one (compound 1) was identified as a hit against methicillin-resistant Staphylococcus aureus (MRSA) strain MW2. METHODS &
RESULTS: The MIC of compound 1 against MRSA was 4 μg/ml. The compound showed enhanced activity at acidic pH by lowering bacterial intracellular pH and exhibited no lysis of human red blood cells at up to 64 μg/ml and its IC50 against HepG2 cells was 32 μg/ml. The compound reduced 1-log10 colony forming units of intracellular MRSA in macrophages and prolonged the survival of MRSA-infected Caenorhabditis elegans (p = 0.0015) and Galleria mellonella (p = 0.0002).
CONCLUSION: Compound 1 is a protonophore with potent in vitro and in vivo activity against MRSA and no toxicity in mammalian cells up to 8 μg/ml that warrants further investigation as a novel antibacterial.

Entities:  

Keywords:  Galleria mellonella; MRSA infection; S. aureus; antibiotic; macrophages; protonophore

Mesh:

Substances:

Year:  2017        PMID: 28771026      PMCID: PMC5941710          DOI: 10.4155/fmc-2017-0047

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  39 in total

1.  Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

Authors:  M E Falagas; L McDermott; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118.

Authors:  A Dalhoff
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

3.  Niclosamide therapy for tapeworm infections.

Authors:  R D Pearson; E L Hewlett
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

4.  Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.

Authors:  M L Beeton; D R Alves; M C Enright; A T A Jenkins
Journal:  Int J Antimicrob Agents       Date:  2015-05-27       Impact factor: 5.283

Review 5.  The role of nasal carriage in Staphylococcus aureus infections.

Authors:  Heiman F L Wertheim; Damian C Melles; Margreet C Vos; Willem van Leeuwen; Alex van Belkum; Henri A Verbrugh; Jan L Nouwen
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

6.  High-throughput screen for novel antimicrobials using a whole animal infection model.

Authors:  Terence I Moy; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Ralph Mazitschek; Gabriele Casadei; Kim Lewis; Anne E Carpenter; Frederick M Ausubel
Journal:  ACS Chem Biol       Date:  2009-07-17       Impact factor: 5.100

7.  In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins.

Authors:  Eric Brouillette; Gilles Grondin; Lulzim Shkreta; Pierre Lacasse; Brian G Talbot
Journal:  Microb Pathog       Date:  2003-10       Impact factor: 3.738

8.  Antiinfectives targeting enzymes and the proton motive force.

Authors:  Xinxin Feng; Wei Zhu; Lici A Schurig-Briccio; Steffen Lindert; Carolyn Shoen; Reese Hitchings; Jikun Li; Yang Wang; Noman Baig; Tianhui Zhou; Boo Kyung Kim; Dean C Crick; Michael Cynamon; J Andrew McCammon; Robert B Gennis; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

9.  Temporal changes in pH within the phagocytic vacuole of the polymorphonuclear neutrophilic leukocyte.

Authors:  M S Jensen; D F Bainton
Journal:  J Cell Biol       Date:  1973-02       Impact factor: 10.539

10.  Protonophore properties of hyperforin are essential for its pharmacological activity.

Authors:  Thomas S Sell; Thabet Belkacemi; Veit Flockerzi; Andreas Beck
Journal:  Sci Rep       Date:  2014-12-16       Impact factor: 4.379

View more
  6 in total

1.  Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus-Caenorhabditis elegans High-Throughput Screen.

Authors:  Nagendran Tharmalingam; Rajmohan Rajmuthiah; Wooseong Kim; Beth Burgwyn Fuchs; Elamparithi Jeyamani; Michael J Kelso; Eleftherios Mylonakis
Journal:  Microb Drug Resist       Date:  2018-02-20       Impact factor: 3.431

2.  Vanadate inhibits Feo-mediated iron transport in Vibrio cholerae.

Authors:  Minhye Shin; Camilo Gomez-Garzon; Shelley M Payne
Journal:  Metallomics       Date:  2021-11-19       Impact factor: 4.636

3.  New solvent options for in vivo assays in the Galleria mellonella larvae model.

Authors:  Beatriz Suay-García; Pedro A Alemán-López; José Ignacio Bueso-Bordils; Antonio Falcó; Gerardo Antón-Fos; María Teresa Pérez-Gracia
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

4.  Effect of new carbonyl cyanide aromatic hydrazones on biofilm inhibition against methicillin resistant Staphylococcus aureus.

Authors:  Xueer Lu; Ziwen Zhang; Yingying Xu; Jun Lu; Wenjian Tang; Jing Zhang
Journal:  RSC Adv       Date:  2020-05-07       Impact factor: 3.361

5.  Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.

Authors:  Nagendran Tharmalingam; Jenna Port; Dawilmer Castillo; Eleftherios Mylonakis
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

6.  The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Rajamohammed Khader; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Front Microbiol       Date:  2019-07-17       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.